|
April 29, 2003
Dr. Alfred O. Berg
Chair, USPSTF
C/o AHRQ
6010 Executive Blvd., Suite 300
Rockville, MD 20852
Dear Dr. Berg:
The American College of
Preventive Medicine (ACPM) is pleased to provide comments
on the draft Recommendation Statement, "Screening for
Ovarian Cancer: Recommendations and Rationale"
developed by the United States Preventive Services Task
Force. ACPM commends the Task Force for addressing this
issue.
In response to your
solicitation ACPM is submitted comments written by one of
its members, Rebecca Ferrini, MD. Dr. Ferrini has
particular expertise in cancer screening and clinical
preventive services. In 1997, Dr. Ferrini drafted
ACPM's policy "Screening for Asymptomatic Women for
Ovarian Cancer". Currently, Dr. Ferrini serves
as Medical Director at San Diego County Edgemoor Hosptial
and she is a faculty member at the University of
California, San Diego, Department of Family and Preventive
Medicine.
Please note that these
comments are those of an independent reviewer and do not
reflect the official view of ACPM nor of Dr.Ferrini’s
affiliations.
Thank you again for the
opportunity to review the draft statement. Please contact
me if you have any questions.
Sincerely,

Michael A. Barry
Deputy Director
ACPM
The American College of Preventive Medicine
1307 New York Avenue, NW
Suite 200
Washington, DC 20005
Tel: 202-466-2044
Contact Person: Jennifer K. Bretsch, MS @ ext. 107 or jkb@acpm.org
________________________________________________________________________
Review of the USPSTF
draft Recommendation Statement on Screening for Ovarian
Cancer: Recommendations and Rationale.
BY: Rebecca Ferrini, MD
FOR: ACPM
DATE: April 29, 2003
Thank you for the
opportunity to read this well-researched and well-written
statement.
I only have one comment.
Under "Recommendations of others" there is a
statement about the ACS recommendations for women with a
"very strong family history," but not for those
without "known strong risk factors." How is a
"very strong family history" or "strong
risk factors" defined? What kind of relative risk are
we talking about here--three times? What factors are they
considering?
Otherwise, outstanding
work!
Rebecca Ferrini, MD
|